author-photo

J.N. Minatta

Hospital Italiano de Buenos Aires

12

Papers

8

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

P60.05 Radiomic Signature to Predict Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P59.22 Biomarker Testing for Advanced Lung Cancer by Next-Generation Sequencing in Real World Practice

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P48.13 Clinical Factors Associated With Treatment Outcomes in EGFR Mutant Non-Small Cell Lung Cancer Patients. Real Life Experience in Argentina

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1174P Preliminary prediction of EGFR-mutant non-small cell lung cancer outcome using radiomic signature

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P24.12 Biomarker Testing for Advanced Lung Cancer by Next-Generation Sequencing in Elderly Patients

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
CheckMate 9KD Arm B final analysis: Efficacy and safety of nivolumab plus docetaxel for chemotherapy-naïve metastatic castration-resistant prostate cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
1726P Expanding the role of medical oncologist in the management of COVID-19

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
LBA52Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (7)